$OVID 3 SEC Filings

Filed On	Filing
08 Jul 2026	Form 3: Carter Charles Ross, Chief Financial Officer Holds 44,375 shares of Common Stock
17 Jun 2026	Form 3: Greka Anna, Director No securities owned
04 Mar 2025	Form 3: Papadopoulos Stelios, Director Holds 200,000 shares of Common Stock
11 Sep 2024	Form 3: Alexander Margaret A., President and COO Holds 28,125 shares of Common Stock
07 Oct 2021	Form 3: Fitzgerald Kevin Joseph, Director No securities owned
12 Jul 2021	Form 3: Poole Robert Michael, Director No securities owned
02 Oct 2020	Form 3: Rona Jeffrey A, Chief Business Officer No securities owned
22 Nov 2019	Form 3: Takeda Pharmaceutical Co Ltd, 10% owner and 1 other Holds 1,781,996 shares of Common Stock
21 Nov 2019	Form 3: Tardio Jason, Chief Commercial Officer No securities owned
26 Mar 2019	Form 3: Perone Thomas Michael, SVP, General Counsel No securities owned
06 Sep 2017	Form 3: Ward Ana, SVP and General Counsel No securities owned
15 Jun 2017	Form 3: Duncan Barbara Gayle, Director No securities owned
04 May 2017	Form 3: Williams Douglas E, Director
04 May 2017	Form 3: Werber Yaron, CBO, CFO, Sec. and Treas.
04 May 2017	Form 3: Rakhit Amit, CMO and PMO
04 May 2017	Form 3: Levin Jeremy M, Director Holds 4,186,045 shares of Common Stock
04 May 2017	Form 3: Haasner Dirk, SVP, Global Regulatory Affairs
04 May 2017	Form 3: Friedman Bart, Director
04 May 2017	Form 3: During Matthew, Director Holds 4,279,069 shares of Common Stock
04 May 2017	Form 3: Daly Timothy, VP, Finance & Corp. Controller

Comments